Painful diabetic neuropathy is more than pain alone: Examining the role of anxiety and depression as mediators and complicators

Rakesh Jain, Shailesh Jain, Charles L Raison, Vladimir Maletic

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

A wealth of information exists regarding the plight of patients suffering with diabetic peripheral neuropathic pain (DPNP). Although physical pain is certainly a primary challenge in the management of this condition, disorders associated with emotional pain-especially depression and anxiety-also greatly complicate the clinician's efforts to attain optimal outcomes for DPNP patients. This article reviews the high rate of comorbidity between DPNP and depression/anxiety with a focus on why this pattern of comorbidity exists and what can be done about it. To accomplish this, the many physiologic similarities between neuropathic pain and depression/anxiety are reviewed as a basis for better understanding how, and why, optimal treatment strategies use behavioral and pharmacologic modalities known to improve both physical pain and symptoms of depression and anxiety. We conclude by highlighting that screening, diagnosing, and optimally treating comorbid depression/anxiety not only improves quality of life, these but also positively impacts DPNP pain.

Original languageEnglish (US)
Pages (from-to)275-284
Number of pages10
JournalCurr Diab Rep
Volume11
Issue number4
DOIs
StatePublished - Aug 2011
Externally publishedYes

Fingerprint

Diabetic Neuropathies
Neuralgia
Anxiety
Depression
Pain
Comorbidity
Quality of Life

Keywords

  • α-2-δ ligands
  • Anxiety
  • Central sensitization
  • Depressive symptoms
  • Diabetes mellitus
  • Diabetic peripheral neuropathic pain (DPNP)
  • Duloxetine
  • Inflammation
  • Kindling
  • Major depression
  • Peripheral nerves
  • Pregabalin
  • Prevalence
  • Psychotherapy, Cognitive behavior l therapy
  • Screening instruments
  • Serotonin reuptake inhibitors
  • Serotonin-norepinephrine reuptake inhibitors
  • Tricyclic antidepressants

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Painful diabetic neuropathy is more than pain alone : Examining the role of anxiety and depression as mediators and complicators. / Jain, Rakesh; Jain, Shailesh; Raison, Charles L; Maletic, Vladimir.

In: Curr Diab Rep, Vol. 11, No. 4, 08.2011, p. 275-284.

Research output: Contribution to journalArticle

@article{4799fe76a70147eb8438e4721b55cd15,
title = "Painful diabetic neuropathy is more than pain alone: Examining the role of anxiety and depression as mediators and complicators",
abstract = "A wealth of information exists regarding the plight of patients suffering with diabetic peripheral neuropathic pain (DPNP). Although physical pain is certainly a primary challenge in the management of this condition, disorders associated with emotional pain-especially depression and anxiety-also greatly complicate the clinician's efforts to attain optimal outcomes for DPNP patients. This article reviews the high rate of comorbidity between DPNP and depression/anxiety with a focus on why this pattern of comorbidity exists and what can be done about it. To accomplish this, the many physiologic similarities between neuropathic pain and depression/anxiety are reviewed as a basis for better understanding how, and why, optimal treatment strategies use behavioral and pharmacologic modalities known to improve both physical pain and symptoms of depression and anxiety. We conclude by highlighting that screening, diagnosing, and optimally treating comorbid depression/anxiety not only improves quality of life, these but also positively impacts DPNP pain.",
keywords = "α-2-δ ligands, Anxiety, Central sensitization, Depressive symptoms, Diabetes mellitus, Diabetic peripheral neuropathic pain (DPNP), Duloxetine, Inflammation, Kindling, Major depression, Peripheral nerves, Pregabalin, Prevalence, Psychotherapy, Cognitive behavior l therapy, Screening instruments, Serotonin reuptake inhibitors, Serotonin-norepinephrine reuptake inhibitors, Tricyclic antidepressants",
author = "Rakesh Jain and Shailesh Jain and Raison, {Charles L} and Vladimir Maletic",
year = "2011",
month = "8",
doi = "10.1007/s11892-011-0202-2",
language = "English (US)",
volume = "11",
pages = "275--284",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Painful diabetic neuropathy is more than pain alone

T2 - Examining the role of anxiety and depression as mediators and complicators

AU - Jain, Rakesh

AU - Jain, Shailesh

AU - Raison, Charles L

AU - Maletic, Vladimir

PY - 2011/8

Y1 - 2011/8

N2 - A wealth of information exists regarding the plight of patients suffering with diabetic peripheral neuropathic pain (DPNP). Although physical pain is certainly a primary challenge in the management of this condition, disorders associated with emotional pain-especially depression and anxiety-also greatly complicate the clinician's efforts to attain optimal outcomes for DPNP patients. This article reviews the high rate of comorbidity between DPNP and depression/anxiety with a focus on why this pattern of comorbidity exists and what can be done about it. To accomplish this, the many physiologic similarities between neuropathic pain and depression/anxiety are reviewed as a basis for better understanding how, and why, optimal treatment strategies use behavioral and pharmacologic modalities known to improve both physical pain and symptoms of depression and anxiety. We conclude by highlighting that screening, diagnosing, and optimally treating comorbid depression/anxiety not only improves quality of life, these but also positively impacts DPNP pain.

AB - A wealth of information exists regarding the plight of patients suffering with diabetic peripheral neuropathic pain (DPNP). Although physical pain is certainly a primary challenge in the management of this condition, disorders associated with emotional pain-especially depression and anxiety-also greatly complicate the clinician's efforts to attain optimal outcomes for DPNP patients. This article reviews the high rate of comorbidity between DPNP and depression/anxiety with a focus on why this pattern of comorbidity exists and what can be done about it. To accomplish this, the many physiologic similarities between neuropathic pain and depression/anxiety are reviewed as a basis for better understanding how, and why, optimal treatment strategies use behavioral and pharmacologic modalities known to improve both physical pain and symptoms of depression and anxiety. We conclude by highlighting that screening, diagnosing, and optimally treating comorbid depression/anxiety not only improves quality of life, these but also positively impacts DPNP pain.

KW - α-2-δ ligands

KW - Anxiety

KW - Central sensitization

KW - Depressive symptoms

KW - Diabetes mellitus

KW - Diabetic peripheral neuropathic pain (DPNP)

KW - Duloxetine

KW - Inflammation

KW - Kindling

KW - Major depression

KW - Peripheral nerves

KW - Pregabalin

KW - Prevalence

KW - Psychotherapy, Cognitive behavior l therapy

KW - Screening instruments

KW - Serotonin reuptake inhibitors

KW - Serotonin-norepinephrine reuptake inhibitors

KW - Tricyclic antidepressants

UR - http://www.scopus.com/inward/record.url?scp=80051587135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051587135&partnerID=8YFLogxK

U2 - 10.1007/s11892-011-0202-2

DO - 10.1007/s11892-011-0202-2

M3 - Article

C2 - 21611765

AN - SCOPUS:80051587135

VL - 11

SP - 275

EP - 284

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 4

ER -